Biotechnology
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
AUSTIN, Texas, Aug. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, August 14, at 8:30 a.m. Eastern time to discuss its financial and operating results for the second quarter 2020, in addition to providing a b...
2020-08-10 19:30
7925
Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia
SALT LAKE CITY, Aug. 7, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today thatAustralia has been added to the list of countries that have authorized the Logix Smart™ C...
2020-08-07 18:30
9150
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies
SHENZHEN and SHANGHAI, August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immun...
2020-08-06 23:49
9606
I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020
SHANGHAI and GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the six months ...
2020-08-06 20:30
14874
Samsung Biologics launches S-CHOice cell line expression technology
INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) today held an online ceremony to announce the launch of its
proprietary cell line technology, S-CHOice.
2020-08-05 09:09
2983
China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone Deficiency
SHANGHAI and GAITHERSBERG, Md., Aug. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China National Medical Products Administration (...
2020-08-04 20:17
15905
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC
DAEJEON, South Korea, Aug. 3, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to evaluate the combination of each party's clinical candidate, olinvacimab and C-005, a3rd generation of EGFR inhibitor with s...
2020-08-03 21:00
2091
Seegene Allplex(TM) 2019-nCoV Assay (SARS-CoV-2) Gets Expanded FDA Emergency Use Authorization
SEOUL, South Korea, July 30, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) has further expanded the emergency use authorization (EUA) for its Allplex™ 2019-nCoV Assay, a real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COV...
2020-07-30 19:00
2863
First successful trans-femoral mitral valve repair device DragonFly™ performed in China
HANGZHOU, China, July 29, 2020 /PRNewswire/ -- On July 23, 2020, Professor Jian'an Wang's team at the Second Affiliated Hospital of Zhejiang University School of Medicine successfully completed the world's first human clinical application of the transcatheter mitral valve repair system (Dragon...
2020-07-29 23:00
2686
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generatingde novo crystal structures of high-value targets. Under the terms ...
2020-07-29 07:00
11215
Sherpa Healthcare Partners Announces Close of Oversubscribed Fund
BEIJING, July 27, 2020 /PRNewswire/ -- Sherpa Healthcare Partners is pleased to announce the final closing of the oversubscribed Sherpa Healthcare Fund I, L.P. The fund focuses on early- to growth-stage investment in the healthcare sector to cover companies in biotech, biopharma, medical devices ...
2020-07-28 11:33
2487
K-BioMed Pioneer: VUNO Med®-Fundus AI™ Becomes Korea's First-ever Innovative Medical Device
SEOUL, South Korea, July 27, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer and a member company of theBorn2Global Centre, announced that VUNO Med®-Fundus AI™, its AI-based screening solution for the fundus, gained the honor of being the first-ever Innovative ...
2020-07-27 22:00
2555
Happiness Biotech Announces Financial Results for Fiscal Year Ended March 31, 2020
NANPING, China, July 24, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its financial results for the fiscal year endedMarch 31, 2020. FY 2020 Financial Highlights: ...
2020-07-25 05:00
24597
Gracell Expands Executive Team by Appointment of CMO Dr. Martina Sersch and CFO Dr. Kevin Xie
SHANGHAI and SUZHOU, China, July 23, 2020 /PRNewswire/ -- Internationally renowned clinical-stage immune cell and gene therapy company, Gracell Biotechnologies Co., Ltd. ("Gracell" or "the Company") has announced two appointments to the executive suite. Chief Medical Officer Dr.Martina Sersch, M...
2020-07-23 22:00
2714
Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test
SAN DIEGO and SHANGHAI, July 21, 2020 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitud...
2020-07-21 23:00
2001
GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum
SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...
2020-07-21 22:04
2731
Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales
INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) announced today strong financial results for its fiscal 2020 second
quarter endingJune 30, 2020, maintaining steady business performance with a
high operating margin at 26.4%.
2020-07-21 20:20
16835
PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit
GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European...
2020-07-20 21:00
2028
Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner
SEONGNAM, South Korea and BASEL, Switzerland, July 14, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc.(KOSDAQ: 288330), a clinical stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunch, theBasel Area -based biotech venture accelerator and incubator, today announces tha...
2020-07-15 07:00
14483
Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology
Shanghai, July 13, 2020 /PRNewswire/ -- Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its$32mn Series A financing led by Morningside Ventures, together with its existing investors. Arctic V...
2020-07-14 09:30
3120
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 334 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 307 media titles]
2025-01-18 17:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 304 media titles]
2025-01-20 14:27
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 302 media titles]
2025-01-21 16:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 288 media titles]
2025-01-20 21:09
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
9917
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
8954
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
8916
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
8753